Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Sep 18, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eli Lilly & Co
|
0
|
—
|
—
|
—
|
0
| ||||||||
Eli Lilly & Co
| 11 |
$923.54 | $10,158.94 | +0.50% | 2.19K |
Sep 16
| |||||||
Eli Lilly & Co
| 16 |
$923.54 | $14,776.64 | +0.10% | 15.81K |
Sep 16
| |||||||
Eli Lilly & Co
| 10 |
$923.54 | $9,235.40 | +0.37% | 2.69K |
Sep 16
| |||||||
Eli Lilly & Co
| 11 |
$923.54 | $10,158.94 | +0.72% | 1.54K |
Sep 16
| |||||||
Eli Lilly & Co
| 13 |
$923.54 | $12,006.02 | +0.02% | 54.25K |
Sep 16
| |||||||
Eli Lilly & Co
| -5.83K |
—
|
—
| -4.72% | 117.9K | +1 |
Sep 10 - Sep 11
| ||||||
Eli Lilly & Co
| -24.08K |
$966.69 | -$23,281,840.23 | -0.02% | 96.89M |
Sep 3
| |||||||
Eli Lilly & Co
| -24.55K |
$968.46 | -$23,777,667.73 | -0.03% | 96.92M |
Aug 27
| |||||||
Eli Lilly & Co
| -750.00 |
$950.00 | -$712,500.00 | -10.52% | 6.38K | +2 |
Aug 26
|
Scheduled
| |||||
Eli Lilly & Co
| -3.20K |
$966.33 | -$3,088,381.87 | -0.00% | 96.94M |
Aug 22
| |||||||
Eli Lilly & Co
| 11 |
$921.81 | $10,139.91 | +0.51% | 2.18K |
Aug 19
| |||||||
Eli Lilly & Co
| 16 |
$921.81 | $14,748.96 | +0.10% | 15.77K |
Aug 19
| |||||||
Eli Lilly & Co
| 10 |
$921.81 | $9,218.10 | +0.38% | 2.67K |
Aug 19
| |||||||
Eli Lilly & Co
| 11 |
$921.81 | $10,139.91 | +0.73% | 1.52K |
Aug 19
| |||||||
Eli Lilly & Co
| 13 |
$921.81 | $11,983.53 | +0.02% | 54.16K |
Aug 19
| |||||||
Eli Lilly & Co
| -14.70K |
—
|
—
| -48.23% | 15.78K | +1 |
Aug 12
| ||||||
Eli Lilly & Co
|
0
|
—
|
—
|
—
|
0
| +1 |
Aug 1
| ||||||
Eli Lilly & Co
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Eli Lilly & Co
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Eli Lilly & Co
| 10 |
$950.46 | $9,504.60 | +0.46% | 2.17K |
Jul 15
| |||||||
Eli Lilly & Co
| 16 |
$950.46 | $15,207.36 | +0.10% | 15.75K |
Jul 15
| |||||||
Eli Lilly & Co
| 10 |
$950.46 | $9,504.60 | +0.38% | 2.66K |
Jul 15
| |||||||
Eli Lilly & Co
| 10 |
$950.46 | $9,504.60 | +0.67% | 1.51K |
Jul 15
| |||||||
Eli Lilly & Co
| 12 |
$950.46 | $11,405.52 | +0.02% | 54.15K |
Jul 15
| |||||||
Eli Lilly & Co
| -210.00K |
$939.82 | -$197,361,397.76 | -0.22% | 96.94M |
Jul 10
| |||||||
Eli Lilly & Co
| -93.59K |
$918.64 | -$85,977,953.61 | -0.10% | 97.15M |
Jul 8
| |||||||
Eli Lilly & Co
| -52.37K |
$915.18 | -$47,927,193.52 | -0.05% | 97.25M |
Jul 5
| |||||||
Eli Lilly & Co
| -8.85K |
$915.31 | -$8,098,654.51 | -0.01% | 97.3M |
Jul 3
| |||||||
Eli Lilly & Co
| -58.75K |
$915.26 | -$53,770,776.28 | -0.06% | 97.31M |
Jul 1
| |||||||
Eli Lilly & Co
| -1.44K |
$915.02 | -$1,318,545.26 | -0.00% | 97.37M |
Jun 28
| |||||||
Eli Lilly & Co
| -188.10K |
$903.82 | -$170,009,262.28 | -0.19% | 97.37M |
Jun 25
| |||||||
Eli Lilly & Co
| -17.23K |
$902.38 | -$15,547,068.30 | -0.02% | 97.56M |
Jun 24
| |||||||
Eli Lilly & Co
| -9.67K |
$902.67 | -$8,729,732.99 | -0.01% | 97.57M |
Jun 20
| |||||||
Eli Lilly & Co
| 11 |
$885.01 | $9,735.11 | +0.51% | 2.15K |
Jun 17
| |||||||
Eli Lilly & Co
| 17 |
$885.01 | $15,045.17 | +0.11% | 15.74K |
Jun 17
| |||||||
Eli Lilly & Co
| 11 |
$885.01 | $9,735.11 | +0.42% | 2.65K |
Jun 17
| |||||||
Eli Lilly & Co
| 11 |
$885.01 | $9,735.11 | +0.74% | 1.5K |
Jun 17
| |||||||
Eli Lilly & Co
| 13 |
$885.01 | $11,505.13 | +0.02% | 54.14K |
Jun 17
| |||||||
Eli Lilly & Co
| -194.98K |
$885.91 | -$172,733,708.05 | -0.20% | 97.58M |
Jun 17
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.